Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 1, 2009, Pages 28-40

  Zawislak, A ^a   Donnelly, R F ^b   McCluggage, W G ^a   Price, J H ^a   McClelland, H R ^a   Woolfson, A D ^b   Dobbs, S ^a   Maxwell, P ^a   McCarron, P A ^c  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Aminolevulinic acid; Bioadhesive; Patch; Photodynamic therapy; Vulval intraepithelial neoplasia

Indexed keywords

AMINOLEVULINIC ACID; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTOPORPHYRIN;

ADULT; AGED; ANALGESIA; ARTICLE; BIOADHESIVE PATCH; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DYSURIA; EDEMA; ERYTHEMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; PAIN; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; STATISTICAL ANALYSIS; TREATMENT RESPONSE; VULVA DISEASE; VULVA INTRAEPITHELIAL NEOPLASIA;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOLEVULINIC ACID; CERVICAL INTRAEPITHELIAL NEOPLASIA; DRUG CARRIERS; FEMALE; HUMANS; MIDDLE AGED; PHOTOSENSITIZING AGENTS; TISSUE ADHESIVES; TREATMENT OUTCOME; VULVAR NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 67349091158     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.03.004     Document Type: Article

References (44)

1. Jones R.W., Baranyai J., and Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 90 (1997) 448-452
2. Joura E.A., Losch A., Haider-Angeler M.G., Breitenecker G., and Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45 (2000) 613-615
3. Jones R.W. Regarding management of VIN 3. Int J Gynecol Cancer 9 (1999) 264
4. Thuesen B., Andreasson B., and Bock J.E. Sexual function and somatopsychic reactions after local excision of vulvar intra-epithelial neoplasia. Acta Obstet Gynecol Scand 71 (1992) 126-128
5. Reid R. Superficial laser vulvectomy. I. The efficacy of extended superficial ablation for refractory and very extensive condylomas. Am J Obstet Gynecol 15 151 (1985) 1047-1052
6. Kuppers V., Stiller M., Somville T., and Bender H.G. Risk factors for recurrent VIN. The role of multifocality of disease. J Reprod Med 42 (1997) 140-144
7. Hillemanns P., Untch M., Dannecker C., et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer 85 (2000) 649-653
8. Fehr M.K., Hornung R., Schwarz V.A., Simeon R., Haller U., and Wyss P. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol 80 (2001) 62-66
9. Abdel-Hady E.S., Martin-Hirsch P., Duggan-Keen M., et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 61 (2001) 192-196
10. Peng Q., Warloe T., Berg K., et al. 5-aminolevulinc acid based photodynamic therapy. Clinical research and future challenge. Cancer 79 (1997) 2282-2308
11. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 (1990) 143-148
12. Kennedy J.C., Marcus S.L., and Pottier R.H. Photodynamic therapy and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid; mechanism and clinical research. J Clin Laser Med Surg 14 (1996) 289-304
13. Corti L., Mazzarotto R., Belfontali S., et al. Photodynamic therapy in gynaecological neoplastic diseases. J Photochem Photobiol B 36 (1996) 193-197
14. Fehr M.K., Hornung R., Degen A., et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med 30 (2002) 273-279
15. Gannon M.J., and Brown S.B. Photodynamic therapy and its applications in gynaecology. B J Obstet Gynaecol 106 (1999) 1246-1254
16. McCarron P.A., Ma L.W., Juzenas P., et al. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J Environ Pathol Toxicol Oncol 25 (2006) 389-402
17. McCarron P.A., Donnelly R.F., Zawislak A., and Woolfson A.D. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci 27 (2006) 268-279
18. McCarron P.A., Donnelly R.F., Zawislak A., Woolfson A.D., Price J.H., and McClelland R. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm 293 (2005 April) 11-23
19. Kessel D., and Luo Y. Mitichondrial photodamage ad PDT induced apoptosis. J Photochem Photobiol B 42 (1998) 89-95
20. He X.Y., Sikes R.A., Thomsen S., Chung L.W., and Jaques S.L. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol 5 59 (1994) 468-473
21. ® AN-139 Production Bulletin, ISP Europe Ltd.; 1996.
22. McCarron P.A., Woolfson A.D., Donnelly R.F., Andrews G.P., Zawislak A., and Price J.H. Influence of plasticiser type and storage conditions on the properties of poly(methyl vinyl ether-co-maleic anhydride) bioadhesive films. J Appl Polym Sci 91 (2004) 1576-1589
23. Zawislak A.A., Price J.H., Dobbs S.P., McClelland H.R., and McCluggage W.G. The management of vulval intraepithelial neoplasia in Northern Ireland. Int J Gynecol Cancer 16 (2006) 780-785
24. Morton C.A., Brown S.B., Collins S., et al. guidelines for topical photodynamic therapy: a report of a workshop of the British photodermatology group. Br J Dermatol 146 (2002) 552-567
25. Fehr M.K., Chapman C.F., Krasieva T., McCullough J.L., and Berns M.W. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol 174 (1996) 951-957
26. Hillemanns P., Weingandt H., Stepp H., et al. Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. Am J Obstet Gynecol 183 (2000) 52-57
27. Jones R.W., Rowan D.M., and Stewart A.W. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 106 (2005) 1319-1326
28. Rosenthal A.N., Hopster D., Ryan A., and Jacobs I.J. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Br J Cancer 27 88 (2003) 251-256
29. Nogueira M.C., Guedes Neto Ede P., Rosa M.W., Zettler E., and Zettler C.G. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 12 (2006) 153-157
30. Val I.C., Almeida Gf, Valiante P.M., et al. Vulvar intraepithelial neoplasia p53 expression in recurrent/progressive cases. J Reprod Med 49 (2004) 868-874
31. Kohlberger P.D., Kirnbauer R., Bncher D., et al. Absence of p53 overexpression in precancerous lesions of the vulva. Cancer 82 (1998) 323-327
32. Roninson I.B. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 8 179 (2002) 1-14
33. Weinberg W.C., and Denning M.F. P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13 (2002) 453-464
34. Knopp S., Bjorge T., Nesland J.M., Trope C., Scheistroen M., and Holm R. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. Gynecol Oncol 95 (2004) 37-45
35. Yamaguchi S., Tsuda H., Takemori M., et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 69 (2005) 110-116
36. Ichimura H., Yamaguchi S., Kojima A., et al. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol 8 (2003) 322-325
37. van Hoeven K.H., and Kovatich A.J. Immunohistochemical staining for proliferating cell nuclear antigen, Bcl-2 and Ki-67 in vulvar tissues. Int J Gynecol Pathol 15 (1996) 10-16
38. Scopa C.D., Tsamandas A.C., Zolota V., Kalofonos H.P., Batistatou A., and Vagianos C. Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study. Dig Dis Sci 48 (2003) 1990-1997
39. Baisch H. Elevated Ki-67 expression is correlated with TNFalpha- and IFNgamma-induced apoptosis in tumour cells. Cell Prolif 35 (2002) 333-342
40. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 (2000) 311-322
41. van Beurden M., de Craen A.J., de Vet H.C., et al. The contribution of MIB 1 in the accurate grading of vulvar intraepithelial neoplasia. J Clin Pathol 52 (1999) 820-824
42. Nakaseko H., Kobayashi M., Akita Y., Tamada Y., and Matsumoto Y. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol 148 (2003) 122-127
43. Shahzidi S., Stokke T., Soltani H., Nesland J.M., and Peng Q. Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line320DM. J Environ Pathol Toxicol Oncol 25 (2006) 159-171
44. Gad F., Viau G., Boushira M., Bertrand R., and Bissonnette R. Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells. J Cutan Med Surg 5 (2001) 8-13